Fixed Dose Combination Orally Disintegrating Tablets to Treat Cardiovascular Disease: Formulation, in vitro Characterization and Physiologically Based Pharmacokinetic Modelling to Assess Bioavailability
Collection Method: The Excel files contain dissolution data for both single and FDC formulations, which have been corrected for samples withdrawn under sink conditions. Data is also included for Caco-2 drug permeability studies and show the mass transfer of drug from both A-B and B-A directions over the study period
Research output: Contribution to journal › Article › peer-review
Open Access
File
Cite this
DataSetCite
Dennision, T. (Creator), Smith, J. (Creator), Badhan, R. (Creator), Mohammed, A. (Creator) (3 Feb 2017). Fixed Dose Combination Orally Disintegrating Tablets to Treat Cardiovascular Disease: Formulation, in vitro Characterization and Physiologically Based Pharmacokinetic Modelling to Assess Bioavailability. Aston Data Explorer. 10.17036/researchdata.aston.ac.uk.00000178